Trials / Completed
CompletedNCT00648973
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses
Evaluation of Nasal Congestion Clinical Efficacy for Diphenhydramine 25 mg and Diphenhydramine 50 mg in Seasonal Allergic Rhinitis: a Randomized, Double-blind, Placebo and Pseudoephedrine Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,021 (actual)
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide · Industry
- Sex
- All
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study was to determine if the drug worked to relieve nasal congestion experienced by people with seasonal allergies.
Detailed description
Subjects who met the inclusion/exclusion criteria were enrolled into the placebo run-in phase of the study on Day -7 (prerandomization, Visit 1). Baseline symptom scores were established during this run-in phase. Subjects with moderate nasal congestion who took at least 80% of their study medication during the run-in phase were eligible for enrollment in the two-week double-blind phase of the study and were randomized on Day 1 (randomization, Visit 2). They were treated for two weeks with their assigned medication. The severity of signs/symptoms were evaluated by the subjects every morning and night and by the investigator at each visit on Day 7 and Day 14. In addition, the subject and investigator provided a global evaluation of response to treatment on Day 7 and Day 14. Safety was evaluated by adverse events reported during the study, vital signs, and the incidence of somnolence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diphenhydramine 50 mg | Three times daily: two diphenhydramine 25 mg capsules Twice daily: one pseudoephedrine-matching placebo tablet |
| DRUG | Diphenhydramine 25 mg | Three times daily: one diphenhydramine 25 mg capsule and one diphenhydramine-matching placebo capsule Twice daily: one pseudoephedrine-matching placebo tablet |
| DRUG | Pseudoephedrine 120 mg | Three times daily: two diphenhydramine-matching placebo capsules Twice daily: one pseudoephedrine 120 mg tablet |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2008-04-01
- Last updated
- 2011-08-22
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00648973. Inclusion in this directory is not an endorsement.